Table 3.

Harm types by system with examples, N = 1762

System, n (%)Harm, n (% of system)Examples
General
186 (10.6)
Generally unwell63 (33.9)75-year-old female felt dizzy and sleepy after taking donepezil. Mild severity, not preventable.
Fatigue47 (25.3)
Weight change24 (12.9)10-year-old male experienced anorexia and poor weight gain on methylphenidate. Mild severity, potentially preventable.
Exacerbation of existing condition20 (10.8)
Other32 (17.2)
Gastroenterology
387 (22.0)
Nausea, vomiting, and diarrhoea213 (55.0)2-year-old female developed diarrhoea after takingamoxicillin. Mild severity, not preventable.
Constipation53 (13.7)81-year-old male developed severe constipation from codeine requiring hospitalisation. Severe harm, potentially preventable.
Dyspepsia48 (12.4)
Bleeding28 (7.2)
Pain12 (3.1)
Other33 (8.5)
Cardiology
217 (12.3)
Hypotension136 (62.7)93-year-old male experienced recurrent falls secondary to hypotension while taking cilazapril, metoprolol, frusemide, and isosorbide mononitrate. Moderate severity, potentially preventable.
Heart failure39 (18.0)
Arrhythmias27 (12.4)
Other15 (6.9)
Neurology
192 (10.9)
Cognition61 (31.8)83-year-old female experinced a haemorrhagic cerebrovascular accident after commencing aspirin and clopidogrel, resulting in death. Not preventable.
Sensory41 (21.4)
Headache35 (18.2)
Balance32 (16.7)79-year-old male developed postural hypotension while taking metoprolol and cilazapril. Fell and developed a subdural haemaotoma, died during hospitalisation. Potentially preventable.
Movement12 (6.3)
Intracerebral event11 (5.7)
Renal
161 (9.1)
Renal139 (86.3)69-year-old male with severe chronic renal failure died within 2 weeks of an increased dose of metformin and allopurinol. Death, potentially preventable.
Urology22 (13.7)
Musculoskeletal
107 (6.1)
Pain75 (70.1)81-year-old male experienced repeated episodes of gout while taking bendrofluazide. Mild severity, potentially preventable.
Gout18 (16.8)
Bones and joints14 (13.1)
Skin
104 (5.9)
Rash50 (48.1)8-year-old female developed scalp irritation and discomfort after using malathion shampoo. Mild severity, not preventable.
Itch23 (22.1)
Other31 (29.8)
Mental health
101 (5.7)
Mood/affect66 (65.3)53-year-old male experienced vivid dreams and sleep disturbance while taking varenicline. Mild severity, not preventable.
Sleep disturbance26 (25.7)
Addiction9 (8.9)43-year-old female described as abusing prescribed codeine. Moderate severity, potentially preventable.
Haematology
81 (4.6)
Haematology77 (95.1)49-year-old male developed thrombocytopenia while taking carbamazebine. Mild severity, not preventable.
Immunology4 (4.9)
Endocrine
71 (4.0)
Diabetes related48 (67.6)71-year-old female taking glipizide and insulin experienced recurrent hypoglycaemic episodes. Moderate severity, potentially preventable.
Sweating and flushing10 (14.1)
Other13 (18.3)
Reproductive health
60 (3.4)
Bleeding34 (56.7)51-year-old female on dabigatran experienced menorrhagia requiring a blood transfusion. Moderate severity, not preventable.
Infection/discharge18 (30.0)
Pregnancy8 (13.3)
Respiratory
57 (3.2)
Cough and wheeze57 (100)71-year-old male developed acute pneumonitis while taking amiodarone. Severe harm, not preventable.
Economic
38 (2.2)
Extra treatment required38 (100)32-year-old male required hospitalisation and time off work for a gastrointestinal bleed while taking diclofenac and no proton-pump inhibitor. Moderate severity, potentially preventable.